TACTIVE-U: Phase 1b/2 umbrella study of ARV-471, a proteolysis targeting chimera (PROTAC) estrogen receptor (ER) degrader, combined with other anticancer treatments in ER+ advanced or metastatic ...
Early dose escalation of LAVA-1207, a novel bispecific gamma-delta T-cell engager (Gammabody), in patients with metastatic castration-resistant prostate cancer (mCRPC). † 2 pts experienced TEAEs ...
The Switch 2's new Accessibility menu lets you enable various features to help you use the system if you have visual, auditory, or verbal difficulties. You can tweak the size of system text, toggle a ...
In Philadelphia, voters have their eyes on the heated 3rd Congressional District democratic primary, plus new immigration bills signed by Mayor Cherelle Parker. On this hour of Studio 2, we get ...